Capital Investment Counsel, LLC

Position in GILD — Gilead Sciences, Inc.

CIK 2033609 DENVER, CO

Position in GILD

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$6,262,673

-$553,077 QoQ

Shares Held

49,570

+1.4% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

1.57%

of 13F equity value

Holder Rank

#528

of 2,266 holders

Holding Since

Dec 2023

11 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Capital Investment Counsel, LLC holds $30,068,995 across 6 Drug Manufacturers - General names. GILD ranks #3 (20.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ABBV	AbbVie Inc.	49,388	$12,427,996
2	AMGN	Amgen Inc	20,071	$7,268,110
3	GILD	Gilead Sciences, Inc. This page	49,570	$6,262,673
4	LLY	ELI LILLY & Co	2,935	$3,520,327
5	JNJ	Johnson & Johnson	1,290	$327,621
6	MRK	Merck & Co., Inc.	2,041	$262,268

11 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$6,262,673	49,570	+1.4%	Shares	Sole	2026-07-15
2026-03-31	$6,815,750	48,904	-0.0%	Shares	Sole	2026-04-23
2025-12-31	$6,003,949	48,916	-0.1%	Shares	Sole	2026-02-02
2025-09-30	$5,436,114	48,974	-1.0%	Shares	Sole	2025-11-06
2025-06-30	$5,482,743	49,452	-6.3%	Shares	Sole	2025-08-01
2025-03-31	$5,915,007	52,789	-5.5%	Shares	Sole	2025-05-15
2024-12-31	$5,158,125	55,842	-0.4%	Shares	Sole	2025-01-23
2024-09-30	$4,700,992	56,071	+3.2%	Shares	Sole	2024-11-12
2024-06-30	$3,729,227	54,354	+2.8%	Shares	Sole	2024-08-14
2024-03-31	$3,872,068	52,861	+45.5%	Shares	Sole	2024-08-14
2023-12-31	$2,942,688	36,325	—	Shares	Sole	2024-08-14
No filing history on record for this holder in this stock.